Pulmonary atresia screening: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Pulmonary atresia}} {{CMG}}; {{AE}} ==Overview== There are no established risk factors for [disease name]. OR The most potent risk factor in the development of...")
 
No edit summary
 
Line 3: Line 3:


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}  
==Overview==
==Overview==
There are no established risk factors for [disease name].


OR
There is insufficient evidence to recommend routine screening for [disease/malignancy].  
 
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].


OR
OR


Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
According to the [guideline name], screening for [disease name] is not recommended.


OR
OR


Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
 
==Screening==
==Risk Factors==
There is insufficient evidence to recommend routine screening for [disease/malignancy].
There are no established risk factors for [disease name].


OR
OR


The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
According to the [guideline name], screening for [disease name] is not recommended.


OR
OR


Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
===Common Risk Factors===
*[Condition 1]
*Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
*[Condition 2]
*Common risk factors in the development of [disease name] include:
*[Condition 3]
**[Risk factor 1]
**[Risk factor 2]
**[Risk factor 3]
 
===Less Common Risk Factors===
*Less common risk factors in the development of [disease name] include:
**[Risk factor 1]
**[Risk factor 2]
**[Risk factor 3]


==References==
==References==

Latest revision as of 13:03, 6 July 2020

Pulmonary atresia Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary atresia from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Labratory findings

Electrocardiogram

Chest X Ray

MRI

Echocardiography or Ultrasound

CT Scan

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Pulmonary atresia screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pulmonary atresia screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary atresia screening

CDC on Pulmonary atresia screening

Pulmonary atresia screening in the news

Blogs on Pulmonary atresia screening

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pulmonary atresia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:

  • [Condition 1]
  • [Condition 2]
  • [Condition 3]

References

Template:WH Template:WS